USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
In Vitro Technologies, Inc.
Address:
Empire State Plaza
Baltimore, MD 21233
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $145,289.00 3
STTR Phase I $100,000.00 2
STTR Phase II $249,949.00 1

Award List:

IN VITRO TEST SYSTEM FOR DETERMINING AGENT TOXICITY

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$48,735.00
Agency:
HHS
Principal Investigator:
Frizell L Vaughan
Abstract:
This project is designed to assess the feasibility of employing a human keratinocyte cell culture in an in vitro test system capable of determining the cutaneous toxicity of an environmental chemical. specific project aims include the study of macromolecular cellular events to measure the degree of… More

PREDICTING NEPHROTOXIC POTENTIAL IN VITRO

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$46,670.00
Agency:
HHS
Principal Investigator:
Ruegg, Charles E , Principal Investigator
Abstract:
The goals of this project are to develop and validate an in vitro testing battery which mechanistically predicts the nephrotoxic potential of chemical agents. this in vitro testing battery is designed to detect direct cytotoxicity, hemodynamic, and ph dependent solubility mechanisms of injury.… More

IN VITRO MODELS FOR EVALUATION

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$49,884.00
Agency:
HHS
Principal Investigator:
Charles E Ruegg
Abstract:
The long-term objective is to establish and validate in vitro systems for detecting and studying peroxisomal proliferators (pp), and to assess the hazard of these chemicals to human health. the specific aims of phase i are to establish and evaluate the reliability of in vitro systems including (1)… More

DEVELOPMENT OF AN IN VITRO ESTROGEN MODULATOR ASSAY

Award Year / Program / Phase:
1998 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Gierthy
Research Institution:
Wadsworth Center
RI Contact:
N/A
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / STTR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Gierthy
Research Institution:
Wadsworth Center
RI Contact:
N/A
Abstract:
N/a